Literature DB >> 30046223

Incidence and mortality of stomach cancer in China, 2014.

Lei Yang1, Rongshou Zheng2, Ning Wang1, Yannan Yuan1, Shuo Liu1, Huichao Li1, Siwei Zhang2, Hongmei Zeng2, Wanqing Chen2.   

Abstract

OBJECTIVE: In this study, we aimed to estimate the updated incidence and mortality rate of stomach cancer based on the cancer registration data in 2014, collected by the National Central Cancer Registry of China (NCCRC).
METHODS: In 2017, 339 registries' data were qualified based on the criteria of data quality control of the NCCRC. Cases of stomach cancer were retrieved from the national database. We estimated numbers of stomach cancer cases and deaths in China using age-specific rates and corresponding national population stratified by area, sex, age-group (0, 1-4, 5-9, 10-14, …, 85+). Chinese standard population in 2000 and Segi's world population were applied for age-standardized incidence and mortality rates.
RESULTS: In 2014, 410,400 new stomach cancer cases and 293,800 cancer-associated deaths were estimated to have occurred in China. The crude incidence rate of stomach cancer was 30.00/100,000, age-standardized incidence rates by Chinese standard population (ASIRC) and by world standard population (ASIRW) were 19.62/100,000 and 19.51/100,000, respectively. The crude mortality rate of stomach cancer was 21.48/100,000, age-standardized mortality rates by Chinese (ASMRC) and by world standard population (ASMRW) were 13.44/100,000 and 13.30/100,000, respectively. Incidence and mortality rates in rural areas were both higher than that in urban areas. Stomach cancer has a strong relationship with gender and age. The disease has occurred more frequently among men than women with a male to female ratio of 2.4 for ASIRC. After age group of 40-44 years, incidence rates are substantially higher in men than in women, same pattern was seen for age-specific mortality rates.
CONCLUSIONS: There is still a heavy burden of stomach cancer in China. The incidence and mortality patterns of stomach cancer show substantial gender and regional disparities. Great effort is needed to provide more accessible health services, sufficient financial resources, and adequate cancer-care infrastructure for the Chinese population, especially for people living in rural areas.

Entities:  

Keywords:  Incidence; mortality; population-based; stomach cancer

Year:  2018        PMID: 30046223      PMCID: PMC6037587          DOI: 10.21147/j.issn.1000-9604.2018.03.01

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  16 in total

Review 1.  Incidence and mortality of gastric cancer in China.

Authors:  Ling Yang
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

2.  [Incidence and mortality of stomach cancer in China, 2013].

Authors:  S W Zhang; Z X Yang; R S Zheng; H M Zeng; W Q Chen; J He
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2017-07-23

3.  Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

Authors:  Claudia Allemani; Tomohiro Matsuda; Veronica Di Carlo; Rhea Harewood; Melissa Matz; Maja Nikšić; Audrey Bonaventure; Mikhail Valkov; Christopher J Johnson; Jacques Estève; Olufemi J Ogunbiyi; Gulnar Azevedo E Silva; Wan-Qing Chen; Sultan Eser; Gerda Engholm; Charles A Stiller; Alain Monnereau; Ryan R Woods; Otto Visser; Gek Hsiang Lim; Joanne Aitken; Hannah K Weir; Michel P Coleman
Journal:  Lancet       Date:  2018-01-31       Impact factor: 79.321

Review 4.  Breast cancer in China.

Authors:  Lei Fan; Kathrin Strasser-Weippl; Jun-Jie Li; Jessica St Louis; Dianne M Finkelstein; Ke-Da Yu; Wan-Qing Chen; Zhi-Ming Shao; Paul E Goss
Journal:  Lancet Oncol       Date:  2014-06       Impact factor: 41.316

Review 5.  Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness.

Authors:  D Max Parkin; Freddie Bray
Journal:  Eur J Cancer       Date:  2009-01-06       Impact factor: 9.162

6.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

7.  Comparison of cancer incidence and mortality in three GDP per capita levels in China, 2013.

Authors:  Zhixun Yang; Rongshou Zheng; Siwei Zhang; Hongmei Zeng; Changfa Xia; He Li; Li Wang; Yanhong Wang; Wanqing Chen
Journal:  Chin J Cancer Res       Date:  2017-10       Impact factor: 5.087

8.  Declining trends in prevalence of Helicobacter pylori infection by birth-year in a Japanese population.

Authors:  Miki Watanabe; Hidemi Ito; Satoyo Hosono; Isao Oze; Chieko Ashida; Kazuo Tajima; Hisato Katoh; Keitaro Matsuo; Hideo Tanaka
Journal:  Cancer Sci       Date:  2015-10-30       Impact factor: 6.716

9.  Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014.

Authors:  Kyu-Won Jung; Young-Joo Won; Chang-Mo Oh; Hyun-Joo Kong; Duk Hyoung Lee; Kang Hyun Lee
Journal:  Cancer Res Treat       Date:  2017-03-09       Impact factor: 4.679

10.  Cancer survival in China, 2003-2005: a population-based study.

Authors:  Hongmei Zeng; Rongshou Zheng; Yuming Guo; Siwei Zhang; Xiaonong Zou; Ning Wang; Limei Zhang; Jingao Tang; Jianguo Chen; Kuangrong Wei; Suqin Huang; Jian Wang; Liang Yu; Deli Zhao; Guohui Song; Jianshun Chen; Yongzhou Shen; Xiaoping Yang; Xiaoping Gu; Feng Jin; Qilong Li; Yanhua Li; Hengming Ge; Fengdong Zhu; Jianmei Dong; Guoping Guo; Ming Wu; Lingbin Du; Xibin Sun; Yutong He; Michel P Coleman; Peter Baade; Wanqing Chen; Xue Qin Yu
Journal:  Int J Cancer       Date:  2014-10-03       Impact factor: 7.396

View more
  69 in total

1.  Efficacy and safety of camrelizumab in combination with trastuzumab and chemotherapy as the first-line treatment for patients with HER2-positive advanced gastric cancer.

Authors:  Mengli Xu; Xiangrui Meng; Yao Lu; Feng Wang
Journal:  J Gastrointest Oncol       Date:  2022-04

2.  Diagnostic and prognostic value of MATN3 expression in gastric carcinoma: TCGA database mining.

Authors:  Ding Li; Jianqiu Xu; Xiaochen Dong; Wenjing Chen; Lingling Pan; Hao Jiang; Jingye Pan; Yueyue Huang
Journal:  J Gastrointest Oncol       Date:  2021-08

3.  The T-Cell-Inflammation Status Can Predict Outcomes of Adjuvant Chemotherapy in Patients with Gastric Cancer.

Authors:  Xiaolong Wu; Xiangyu Gao; Xiaofang Xing; Xianzi Wen; Ziyu Li; Jiafu Ji
Journal:  Ann Surg Oncol       Date:  2020-08-07       Impact factor: 5.344

4.  A Comparison of Gastric Cancer Surgery Between Japan and China.

Authors:  Dapeng Liu; Boxiang Zhang; Tomoyuki Matsunaga; Kozo Miyatani; Yuji Shishido; Yusuke Kono; Yoshiyuki Fujiwara
Journal:  Yonago Acta Med       Date:  2019-11-22       Impact factor: 1.641

5.  Low Epstein-Barr Virus Prevalence in Cardia Gastric Cancer Among a High-Incidence Chinese Population.

Authors:  John G Aversa; Minkyo Song; Nan Hu; Alisa M Goldstein; Stephen M Hewitt; Margaret L Gulley; Sanford Dawsey; Maria Constanza Camargo; Philip R Taylor; Charles S Rabkin
Journal:  Dig Dis Sci       Date:  2020-05-04       Impact factor: 3.199

6.  Short-term outcomes of laparoscopic versus open total gastrectomy after neoadjuvant chemotherapy: a cohort study using the propensity score matching method.

Authors:  Yinkui Wang; Xiaokang Lei; Zining Liu; Fei Shan; Xiangji Ying; Ziyu Li; Jiafu Ji
Journal:  J Gastrointest Oncol       Date:  2021-04

7.  Prognostic impact of D2-plus lymphadenectomy and optimal extent of lymphadenectomy in advanced gastric antral carcinoma: Propensity score matching analysis.

Authors:  Weilin Sun; Jingyu Deng; Nannan Zhang; Huifang Liu; Jinyuan Liu; Pengfei Gu; Yingxin Du; Zizhen Wu; Wenting He; Pengliang Wang; Han Liang
Journal:  Chin J Cancer Res       Date:  2020-02       Impact factor: 5.087

8.  Current status of lymph node dissection in gastric cancer.

Authors:  Bin Ke; Han Liang
Journal:  Chin J Cancer Res       Date:  2021-04-30       Impact factor: 5.087

9.  A Novel Inflammatory-Nutritional Prognostic Scoring System for Stage III Gastric Cancer Patients With Radical Gastrectomy Followed by Adjuvant Chemotherapy.

Authors:  Nan Wang; Wenqi Xi; Sheng Lu; Jinling Jiang; Chao Wang; Zhenglun Zhu; Chao Yan; Jing Liu; Jun Zhang
Journal:  Front Oncol       Date:  2021-06-14       Impact factor: 6.244

10.  Microsatellite instability and Epstein-Barr virus combined with PD-L1 could serve as a potential strategy for predicting the prognosis and efficacy of postoperative chemotherapy in gastric cancer.

Authors:  Na Yang; Yanhua Wu; Meishan Jin; Zhifang Jia; Yueqi Wang; Donghui Cao; Lili Qin; Xueying Wang; Min Zheng; Xueyuan Cao; Jing Jiang
Journal:  PeerJ       Date:  2021-05-18       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.